| For: | Chamaillard M, Dessein R. Defensins couple dysbiosis to primary immunodeficiency in Crohn’s disease. World J Gastroenterol 2011; 17(5): 567-571 [PMID: 21350705 DOI: 10.3748/wjg.v17.i5.567] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i5/567.htm |
| Number | Citing Articles |
| 1 |
Kieran G. Meade, Cliona O'Farrelly. β-Defensins: Farming the Microbiome for Homeostasis and Health. Frontiers in Immunology 2019; 9 doi: 10.3389/fimmu.2018.03072
|
| 2 |
Sergei I. Grivennikov. Inflammation and colorectal cancer: colitis-associated neoplasia. Seminars in Immunopathology 2013; 35(2) doi: 10.1007/s00281-012-0352-6
|
| 3 |
Connie WY Ha, Yan Y Lam, Andrew J Holmes. Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health. World Journal of Gastroenterology 2014; 20(44): 16498-16517 doi: 10.3748/wjg.v20.i44.16498
|
| 4 |
Vladimir I Vaschenko, Vladimir N Vil’yaninov, Petr D Shabanov. Antimicrobial and antiviral effects of human defensins: pathogenetic value and prospective application to medicinal therapy. Reviews on Clinical Pharmacology and Drug Therapy 2016; 14(2) doi: 10.17816/RCF1423-37
|
| 5 |
Aggeliki Lyberopoulou, Georgia Chachami, Nikolaos K. Gatselis, Eleni Kyratzopoulou, Asterios Saitis, Stella Gabeta, Petros Eliades, Efrosini Paraskeva, Kalliopi Zachou, George K. Koukoulis, Avgi Mamalaki, George N. Dalekos, George Simos, Pavel Strnad. Low Serum Hepcidin in Patients with Autoimmune Liver Diseases. PLOS ONE 2015; 10(8) doi: 10.1371/journal.pone.0135486
|
| 6 |
Amar Madi, Ziad Alnabhani, Charlène Leneveu, Lily Mijouin, Marc Feuilloley, Nathalie Connil. Pseudomonas fluorescens can induce and divert the human β-defensin-2 secretion in intestinal epithelial cells to enhance its virulence. Archives of Microbiology 2013; 195(3) doi: 10.1007/s00203-012-0865-3
|
| 7 |
Ekaterina S. Umnyakova, Maria S. Zharkova, Mikhail N. Berlov, Olga V. Shamova, Vladimir N. Kokryakov. Human antimicrobial peptides in autoimmunity. Autoimmunity 2020; 53(3) doi: 10.1080/08916934.2020.1711517
|
| 8 |
Joseph Topal, Mads Gyrd-Hansen. RIPK2 NODs to XIAP and IBD. Seminars in Cell & Developmental Biology 2021; 109 doi: 10.1016/j.semcdb.2020.07.001
|
| 9 |
K. Tsilingiri, M. Rescigno. Postbiotics: what else?. Beneficial Microbes 2013; 4(1) doi: 10.3920/BM2012.0046
|
| 10 |
Marta Olivares, J. Moisés Laparra, Yolanda Sanz. Host genotype, intestinal microbiota and inflammatory disorders. British Journal of Nutrition 2013; 109(S2) doi: 10.1017/S0007114512005521
|
| 11 |
R. Kobayashi, T. Kobayashi, F. Sakai, T. Hosoya, M. Yamamoto, T. Kurita-Ochiai. Oral administration of Lactobacillus gasseri SBT2055 is effective in preventing Porphyromonas gingivalis-accelerated periodontal disease. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-00623-9
|
| 12 |
Christopher M. Scheidler, Leonhard M. Kick, Sabine Schneider. Ribosomal Peptides and Small Proteins on the Rise. ChemBioChem 2019; 20(12) doi: 10.1002/cbic.201800715
|
| 13 |
Chi Chen, Praveen Kumar Yadav, Xingpeng Wang, Zhanju Liu. Regulatory role of defensins in inflammatory bowel disease. Open Journal of Immunology 2012; 2(02) doi: 10.4236/oji.2012.22010
|
| 14 |
Mathias Chamaillard, Annabelle Cesaro, Pierre-Emmanuel Lober, Didier Hober. Decoding Norovirus Infection in Crohnʼs Disease. Inflammatory Bowel Diseases 2014; 20(4) doi: 10.1097/01.MIB.0000440613.83703.4a
|